Vidyard Selected as Finalist for MIT Sloan CIO Symposium's

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
241
Vidyard Selected as Finalist for MIT Sloan CIO Symposium's Innovation Showcase

KITCHENER, ON --(Marketwired - May 09, 2017) - The 14th annual MIT Sloan CIO Symposium today announced Vidyard was selected as a top 10 innovator for the 2017 Innovation Showcase . Vidyard's video platform for business was selected based on strategic value and innovation to the digital enterprise now and in the future. At the Symposium on May 24, Vidyard will showcase its leading video platform to a number of the world's most creative and influential IT executives, helping them to embrace video as an integrated part of their marketing, sales, service and internal communications programs.

"If a picture is worth 1000 words, imagine the power of video. Vidyard's video platform for business enables organizations to engage their audience and accelerate business results. With Vidyard, marketing teams can increase leads, sales teams can create more opportunities and customer service teams can achieve higher customer satisfaction," says Jeff Loeb, chief marketing officer at Vidyard. "Over 75,000 professionals use Vidyard to create, host, personalize, monetize and measure their business videos. It's truly innovative."

Vidyard helps marketing, sales, support and management teams create, share, monetize and measure video. Marketing and sales teams accelerate sales cycles by creating personalized and interactive video that drives engagement, captures leads and guides the buyer's journey. Audience engagement data is passed to sales reps via marketing automation platforms (MAP) including Salesforce, Marketo, Eloqua, HubSpot and more. This enables reps to focus on highly engaged and educated prospects and have more targeted and relevant conversations. Global leaders, including Microsoft, McKesson, Lenovo, Cision, Citibank, Dynatrace, MongoDB and Sharp, power their video engagement strategies with Vidyard. Customers can also download Vidyard's free Chrome extension, ViewedIt for screen, voice and webcam recording so that sharing and tracking personalized videos is easy.

"It is with great honor that we recognize these 10 companies for our 2017 Innovation Showcase," said Anton Teodorescu, co-chair of the Innovation Showcase. "The Symposium provides an opportune environment for these early-stage companies to form valuable partnerships with CIOs and a platform to demonstrate their technologies that are building the digital enterprise."

After careful consideration, the Innovation Showcase Judges evaluated and selected Vidyard for this honor based on the following criteria:

  • Have a B2B or B2C enterprise IT solution product in the market
  • Are selling enterprise IT solutions to CIOs or corporate IT departments; and
  • Show innovation and/or strategic value and potential impact on the top and/or bottom lines.

More Information:

For a full list of Innovation Showcase finalists visit http://www.mitcio.com/innovation . The Innovation Showcase will take place at 5:30 p.m. in the Kresge courtyard tent on Wednesday, May 24, 2017, at MIT in Cambridge, MA. The full agenda for the MIT Sloan CIO Symposium is available at www.mitcio.com/agenda .

About Vidyard

Vidyard is the video platform for business that helps organizations drive more revenue through the use of online video. Going beyond video hosting and management, Vidyard helps businesses drive greater engagement in their video content, track the viewing activities of each individual viewer, and turn those views into action. Global leaders such as Microsoft, Honeywell, McKesson, Lenovo, LinkedIn, Cision, Citibank, MongoDB and Sharp rely on Vidyard to power their video content strategies and turn viewers into customers.

About the MIT Sloan CIO Symposium

The MIT Sloan CIO Symposium is the premier global conference for CIOs and digital business executives to become more effective leaders. In one day, CIOs and senior IT executives explore enterprise technology innovations, business practices and receive actionable information that enables them to meet the challenges of today and the future. The Symposium offers a unique learning environment by bringing together the academic thought leadership of MIT with the in-the-trenches experience of leading, global CIOs and industry experts. The MIT Sloan CIO Symposium is organized and developed by the MIT Sloan Boston Alumni Association, the MIT Initiative on the Digital Economy (IDE), and the MIT Sloan Center for Information Systems Research (CISR). For more information and to register for this year's Symposium, visit www.mitcio.com .

Editor's Note:

Journalists interested in press credentials or speaking with any of the Showcase Innovation finalists should contact Caroline Legg ( caroline@warnerpr.com ; 978-255-4488), Warner Communications.

Image Available: http://www.marketwire.com/library/MwGo/2017/5...182d4a.jpg

Vidyard Media Contact: Sandy Pell Senior Manager, Corporate Communications Vidyard Email: press@vidyard.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 595

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 18

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Initiated for Voyager Therapeutics Investors

Updated Category News Views 115

Investigation Overview for Voyager Therapeutics Investors Pomerantz LLP is currently exploring possible claims on behalf of investors in Voyager Therapeutics, Inc. (NASDAQ: VYGR). This exploration arises from concerns surrounding the company’s recent announcements and operational strategies. Details of the Investigation The inquiry focuses on whether Voyager and some of...

Continue Reading
Subway's Creative Middle Seat Reward for Travelers

Updated Category News Views 132

Subway Announces Exciting Promotion for Air Travelers On January 27, a significant change is happening for travelers, especially for those who dread sitting in the middle seat of a plane. With a popular airline ending its open seating policy, millions are gearing up for assigned seating. This means that many passengers might find themselves in the middle seat, which is...

Continue Reading
Expanse Studios Unveils Innovative Games at Major Summit

Updated Category News Views 86

Expanse Studios Shines at Industry Summit Expanse Studios, a cutting-edge gaming developer and a subsidiary of Golden Matrix Group Inc. (NASDAQ: GMGI), has made a significant impression at the recent SBC Summit Lisbon. This event attracted around 25,000 attendees, featuring a mix of gaming innovators and industry experts, all eager to explore what's next in the gaming...

Continue Reading
Unlocking Digital Preservation Skills Through New Academy

Updated Category News Views 150

Introducing the Preservica Academy for Digital Preservation Preservica Inc. has unveiled its exciting new initiative, Preservica Academy, dedicated to enhancing the skills of professionals and beginners in the realm of digital preservation. This innovative program focuses on Active Digital Preservation™, aiming to ensure the long-term accessibility and integrity of...

Continue Reading
Seritage Growth Properties Investors Alert: Class Action Lawsuit Update

Updated Category News Views 107

Notification of Class Action Lawsuit for Seritage Growth Properties Levi & Korsinsky, LLP is reaching out to inform investors of Seritage Growth Properties (NYSE: SRG) regarding an ongoing class action securities lawsuit. This case marks an important development for those affected by alleged securities fraud. Overview of the Class Action Lawsuit This lawsuit is centered...

Continue Reading